Goldberg

6158967 | Joined since 2012-05-02

Investing Experience -
Risk Profile -

Followers

37

Following

0

Blog Posts

2

Threads

2,918

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
2,918
Past 30 days
46
Past 7 days
8
Today
0

User Comments
Stock

2021-01-05 10:31 | Report Abuse

Glovefinish/habisglove/Swagger. They are all employed by syndicates behind the scene to spread fear.
========================================================
Look at their comment history, only 1 counter they are attacking, it's an organized assault in which they open specific accounts to target specific counters. think about it, why glovefinish/habisglove never talked at TG/Harta/Kossan and any other gloves forum? they have their colleagues there taking care for them.

so retailers beware!

Stock

2021-01-05 10:26 | Report Abuse

PUBLIC INVESTMENT BANK
PublicInvest Research Sector Update KDNPP17686/03/2013(032117)
RUBBER GLOVES
Tuesday, January 5, 2021
Overweight

COMPELLING VALUATIONS
======================
RUBBER GLOVES MARKET SHARE

Following the uplifting of the regulated short selling (RSS) suspension, glove makers under our coverage came under heavy selling pressure, with respective share prices declining by 10% to 14% overnight. We are of the view that the extended selldown is rather unwarranted, considering that the fundamentals for glove counters are still intact and stellar results are still expected in the coming quarters, supported by rising gloves’ ASP and tight supplies due to capacity constraints. .

1-No change to fundamentals

Still sound. Despite the unwarranted heavy selldown on glove counters following the uplifting of RSS suspension, fundamentals for the glove makers under our coverage universe remain solid. We expect the glove makers to continue delivering impressive results in the coming quarters. We see an upward ASP trend as the rubber glove supplies continue to be tight due to capacity constraints.

2-Vaccine is not wonder drug.

The rollout of Covid-19 vaccine has greatly dampened the sentiment on glove counters; however, we highlight that glove demand and ASPs are still holding up well, considering the change in consumption pattern and heightened hygiene awareness.
On a side note, with the new Covid strain that is reportedly faster spreading, the existing vaccines developed might not work as effectively in warding off the new strain, potentially prolonging the time needed to inoculate a sufficient percentage of the world population.

3-Buy for its dividends.

Top Glove has committed to special dividend payout of 20%, bringing its total dividend payout for the remaining three quarters in FY21F to 70%.

4-Attractive valuations,

Upgrade to Overweight. Following the recent share price retracement, all three glove makers under our coverage are currently trading at compelling valuation levels.

Stock

2021-01-05 10:25 | Report Abuse

PUBLIC INVESTMENT BANK
PublicInvest Research Sector Update KDNPP17686/03/2013(032117)
RUBBER GLOVES
Tuesday, January 5, 2021
Overweight

COMPELLING VALUATIONS
======================
RUBBER GLOVES MARKET SHARE

Following the uplifting of the regulated short selling (RSS) suspension, glove makers under our coverage came under heavy selling pressure, with respective share prices declining by 10% to 14% overnight. We are of the view that the extended selldown is rather unwarranted, considering that the fundamentals for glove counters are still intact and stellar results are still expected in the coming quarters, supported by rising gloves’ ASP and tight supplies due to capacity constraints. .

1-No change to fundamentals

Still sound. Despite the unwarranted heavy selldown on glove counters following the uplifting of RSS suspension, fundamentals for the glove makers under our coverage universe remain solid. We expect the glove makers to continue delivering impressive results in the coming quarters. We see an upward ASP trend as the rubber glove supplies continue to be tight due to capacity constraints.

2-Vaccine is not wonder drug.

The rollout of Covid-19 vaccine has greatly dampened the sentiment on glove counters; however, we highlight that glove demand and ASPs are still holding up well, considering the change in consumption pattern and heightened hygiene awareness.
On a side note, with the new Covid strain that is reportedly faster spreading, the existing vaccines developed might not work as effectively in warding off the new strain, potentially prolonging the time needed to inoculate a sufficient percentage of the world population.

3-Buy for its dividends.

Top Glove has committed to special dividend payout of 20%, bringing its total dividend payout for the remaining three quarters in FY21F to 70%.

4-Attractive valuations,

upgrade to Overweight. Following the recent share price retracement, all three glove makers under our coverage are currently trading at compelling valuation levels.

Stock

2021-01-05 10:24 | Report Abuse

PUBLIC INVESTMENT BANK
PublicInvest Research Sector Update KDNPP17686/03/2013(032117)
RUBBER GLOVES
Tuesday, January 5, 2021
Overweight

COMPELLING VALUATIONS
======================
RUBBER GLOVES MARKET SHARE

Following the uplifting of the regulated short selling (RSS) suspension, glove makers under our coverage came under heavy selling pressure, with respective share prices declining by 10% to 14% overnight. We are of the view that the extended selldown is rather unwarranted, considering that the fundamentals for glove counters are still intact and stellar results are still expected in the coming quarters, supported by rising gloves’ ASP and tight supplies due to capacity constraints. .

1-No change to fundamentals

Still sound. Despite the unwarranted heavy selldown on glove counters following the uplifting of RSS suspension, fundamentals for the glove makers under our coverage universe remain solid. We expect the glove makers to continue delivering impressive results in the coming quarters. We see an upward ASP trend as the rubber glove supplies continue to be tight due to capacity constraints.

2-Vaccine is not wonder drug.

The rollout of Covid-19 vaccine has greatly dampened the sentiment on glove counters; however, we highlight that glove demand and ASPs are still holding up well, considering the change in consumption pattern and heightened hygiene awareness.
On a side note, with the new Covid strain that is reportedly faster spreading, the existing vaccines developed might not work as effectively in warding off the new strain, potentially prolonging the time needed to inoculate a sufficient percentage of the world population.

3-Buy for its dividends.

Top Glove has committed to special dividend payout of 20%, bringing its total dividend payout for the remaining three quarters in FY21F to 70%.

4-Attractive valuations,

upgrade to Overweight. Following the recent share price retracement, all three glove makers under our coverage are currently trading at compelling valuation levels.

Stock

2021-01-05 10:23 | Report Abuse

PUBLIC INVESTMENT BANK
PublicInvest Research Sector Update KDNPP17686/03/2013(032117)
RUBBER GLOVES
Tuesday, January 5, 2021
Overweight

COMPELLING VALUATIONS
======================
RUBBER GLOVES MARKET SHARE

Following the uplifting of the regulated short selling (RSS) suspension, glove makers under our coverage came under heavy selling pressure, with respective share prices declining by 10% to 14% overnight. We are of the view that the extended selldown is rather unwarranted, considering that the fundamentals for glove counters are still intact and stellar results are still expected in the coming quarters, supported by rising gloves’ ASP and tight supplies due to capacity constraints. .

1-No change to fundamentals

Still sound. Despite the unwarranted heavy selldown on glove counters following the uplifting of RSS suspension, fundamentals for the glove makers under our coverage universe remain solid. We expect the glove makers to continue delivering impressive results in the coming quarters. We see an upward ASP trend as the rubber glove supplies continue to be tight due to capacity constraints.

2-Vaccine is not wonder drug.

The rollout of Covid-19 vaccine has greatly dampened the sentiment on glove counters; however, we highlight that glove demand and ASPs are still holding up well, considering the change in consumption pattern and heightened hygiene awareness.
On a side note, with the new Covid strain that is reportedly faster spreading, the existing vaccines developed might not work as effectively in warding off the new strain, potentially prolonging the time needed to inoculate a sufficient percentage of the world population.

3-Buy for its dividends.

Top Glove has committed to special dividend payout of 20%, bringing its total dividend payout for the remaining three quarters in FY21F to 70%.

4-Attractive valuations,

upgrade to Overweight. Following the recent share price retracement, all three glove makers under our coverage are currently trading at compelling valuation levels.

Stock

2021-01-05 10:22 | Report Abuse

PUBLIC INVESTMENT BANK
PublicInvest Research Sector Update KDNPP17686/03/2013(032117)
RUBBER GLOVES
Tuesday, January 5, 2021
Overweight

COMPELLING VALUATIONS
======================
RUBBER GLOVES MARKET SHARE

Following the uplifting of the regulated short selling (RSS) suspension, glove makers under our coverage came under heavy selling pressure, with respective share prices declining by 10% to 14% overnight. We are of the view that the extended selldown is rather unwarranted, considering that the fundamentals for glove counters are still intact and stellar results are still expected in the coming quarters, supported by rising gloves’ ASP and tight supplies due to capacity constraints. .

1-No change to fundamentals

Still sound. Despite the unwarranted heavy selldown on glove counters following the uplifting of RSS suspension, fundamentals for the glove makers under our coverage universe remain solid. We expect the glove makers to continue delivering impressive results in the coming quarters. We see an upward ASP trend as the rubber glove supplies continue to be tight due to capacity constraints.

2-Vaccine is not wonder drug.

The rollout of Covid-19 vaccine has greatly dampened the sentiment on glove counters; however, we highlight that glove demand and ASPs are still holding up well, considering the change in consumption pattern and heightened hygiene awareness.
On a side note, with the new Covid strain that is reportedly faster spreading, the existing vaccines developed might not work as effectively in warding off the new strain, potentially prolonging the time needed to inoculate a sufficient percentage of the world population.

3-Buy for its dividends.

Top Glove has committed to special dividend payout of 20%, bringing its total dividend payout for the remaining three quarters in FY21F to 70%.

4-Attractive valuations,

Upgrade to Overweight. Following the recent share price retracement, all three glove makers under our coverage are currently trading at compelling valuation levels.

Stock

2021-01-05 10:20 | Report Abuse

PUBLIC INVESTMENT BANK
PublicInvest Research Sector Update KDNPP17686/03/2013(032117)
RUBBER GLOVES
Tuesday, January 5, 2021
Overweight

COMPELLING VALUATIONS
======================
RUBBER GLOVES MARKET SHARE

Following the uplifting of the regulated short selling (RSS) suspension, glove makers under our coverage came under heavy selling pressure, with respective share prices declining by 10% to 14% overnight. We are of the view that the extended selldown is rather unwarranted, considering that the fundamentals for glove counters are still intact and stellar results are still expected in the coming quarters, supported by rising gloves’ ASP and tight supplies due to capacity constraints. .

1-No change to fundamentals

Still sound. Despite the unwarranted heavy selldown on glove counters following the uplifting of RSS suspension, fundamentals for the glove makers under our coverage universe remain solid. We expect the glove makers to continue delivering impressive results in the coming quarters. We see an upward ASP trend as the rubber glove supplies continue to be tight due to capacity constraints.

2-Vaccine is not wonder drug.

The rollout of Covid-19 vaccine has greatly dampened the sentiment on glove counters; however, we highlight that glove demand and ASPs are still holding up well, considering the change in consumption pattern and heightened hygiene awareness.
On a side note, with the new Covid strain that is reportedly faster spreading, the existing vaccines developed might not work as effectively in warding off the new strain, potentially prolonging the time needed to inoculate a sufficient percentage of the world population.

3-Buy for its dividends.

Top Glove has committed to special dividend payout of 20%, bringing its total dividend payout for the remaining three quarters in FY21F to 70%.

4-Attractive valuations,

upgrade to Overweight. Following the recent share price retracement, all three glove makers under our coverage are currently trading at compelling valuation levels.

Stock

2021-01-04 21:29 | Report Abuse

In terms of valuation and dividends point of view, gloves do provide very good value at this point of time,” said Goh, at Credit Suisse's 2021 ASEAN Conference media briefing today.

Based on feedback from the glove makers, Goh said the average selling price is still trending upwards on a quarter-on-quarter basis, noting that 2021 “earnings is pretty much already in the bag”.

Stock

2021-01-04 21:22 | Report Abuse

KUALA LUMPUR (Jan 4): Despite the availability of vaccines seen around the globe, Credit Suisse is still positive on the glove sector due to its inexpensive valuation and higher dividends.

Credit Suisse’s co-head of ASEAN securities research and head of research in Malaysia Danny Goh said the glove sector is trading at less than five times P/E multiple versus its historic average of 17%, and is at present offering a dividend of more than 10%.

“Thus, in terms of valuation and dividends point of view, gloves do provide very good value at this point of time,” said Goh, at Credit Suisse's 2021 ASEAN Conference media briefing today.

Based on feedback from the glove makers, Goh said the average selling price is still trending upwards on a quarter-on-quarter basis, noting that 2021 “earnings is pretty much already in the bag”.

“While the pandemic does pose some question marks on how long demand and selling prices could continue to stay firm, but if we were to rely on the feedback of some of the glove makers, the forward orders will last them well into 2022,” he added.

Stock

2021-01-04 20:58 | Report Abuse

IBs./Short Sellers May Panic Tomorrow.
----------------------------------------
Minority Shareholder Watch Group (MSWG) CEO Devanesan Evanson opined that Top Glove’s latest announcement will augur well for minority shareholders who prefer dividend yield stocks.

“This announcement will certainly add to their confidence. There has been a routing of all the large glove stocks today and the announcement will certainly mitigate the fall in Top Glove’s share price,” he told FocusM.

Asked if Top Glove was pressured to issue such a commitment in view of the massive sell-off that took place, Devanesan said: “It is unlikely that Top Glove will not honour the commitment. We have to give them the benefit of the, doubt.”

Nevertheless, the MSWG head honcho deemed Top Glove’s announcement as a smart move to arrest sell orders of its stocks to some extent.

“Investors who may have been thinking of selling their shares due to the rout on Top Glove shares may now not do so due to the committed increased dividend yield,” he suggested.

“What makes it more attractive is that the increased dividend will be paid on a quarterly basis for the current year. There is a sense of immediacy of cash flow for the investors.”

Perhaps, this is after all a better move if pitted against company share buyback exercise (or even personal share acquisition) which Top Glove is so prone of embarking upon.

Stock

2021-01-04 20:47 | Report Abuse

Wise words by Warrant Buffett
-------------------------------

No point talking about TA or FA when the price is crashing. If your conviction is strong, you either KEEP or BUY more. It's time for the transfer of wealth/money from the impatient/fearful to the patient/brave.

"Unless you can watch your stock holding decline by 50% without becoming panic-stricken, you should not be in the stock market." -Warren Buffett.

Stock

2021-01-04 20:45 | Report Abuse

Wise words by Warrant Buffett
-------------------------------

No point talking about TA or FA when the price is crashing. If your conviction is strong, you either KEEP or BUY more. It's time for the transfer of wealth/money from the impatient/fearful to the patient/brave.

"Unless you can watch your stock holding decline by 50% without becoming panic-stricken, you should not be in the stock market." -Warren Buffett.

Stock

2021-01-04 20:43 | Report Abuse

Wise words by Warren Buffett
-------------------------------

No point talking about TA or FA when the price is crashing. If your conviction is strong, you either KEEP or BUY more.

It's time for the transfer of wealth/money from the impatient/fearful to the patient/brave.

"Unless you can watch your stock holding decline by 50% without becoming panic-stricken, you should not be in the stock market." -Warren Buffett.

Stock

2021-01-04 20:37 | Report Abuse

Credit Suisse still POSITIVE on glove sector due to Attractive Valuation.
==================================================
TheEdge Mon, Jan 04, 2021 02:38pm - 5 hours ago


KUALA LUMPUR (Jan 4): Despite the availability of vaccines seen around the globe, Credit Suisse is still positive on the glove sector due to its inexpensive valuation and higher dividends.

Credit Suisse’s co-head of ASEAN securities research and head of research in Malaysia Danny Goh said the glove sector is trading at less than five times P/E multiple versus its historic average of 17%, and is at present offering a dividend of more than 10%.

“Thus, in terms of valuation and dividends point of view, gloves do provide very good value at this point of time,” said Goh, at Credit Suisse's 2021 ASEAN Conference media briefing today.

Based on feedback from the glove makers, Goh said the average selling price is still trending upwards on a quarter-on-quarter basis, noting that 2021 “earnings is pretty much already in the bag”.

“While the pandemic does pose some question marks on how long demand and selling prices could continue to stay firm, but if we were to rely on the feedback of some of the glove makers, the forward orders will last them well into 2022,” he added.

From this perspective, he noted that glove stocks do seem defensive at this point of time, given that it is one of the few sectors that is seeing positive earnings momentum, offering very high dividend yield and trading at very low valuation relative to history.

As at noon break today, the big four rubber glove makers have wiped out RM13.65 billion worth of market capitalisation on Bursa Malaysia, due to the strong selling pressure that is possibly no thanks to the short selling ban that has been lifted as of today.

Stock

2021-01-04 20:36 | Report Abuse

Credit Suisse still POSITIVE on glove sector due to Attractive Valuation.
==================================================
TheEdge Mon, Jan 04, 2021 02:38pm - 5 hours ago


KUALA LUMPUR (Jan 4): Despite the availability of vaccines seen around the globe, Credit Suisse is still positive on the glove sector due to its inexpensive valuation and higher dividends.

Credit Suisse’s co-head of ASEAN securities research and head of research in Malaysia Danny Goh said the glove sector is trading at less than five times P/E multiple versus its historic average of 17%, and is at present offering a dividend of more than 10%.

“Thus, in terms of valuation and dividends point of view, gloves do provide very good value at this point of time,” said Goh, at Credit Suisse's 2021 ASEAN Conference media briefing today.

Based on feedback from the glove makers, Goh said the average selling price is still trending upwards on a quarter-on-quarter basis, noting that 2021 “earnings is pretty much already in the bag”.

“While the pandemic does pose some question marks on how long demand and selling prices could continue to stay firm, but if we were to rely on the feedback of some of the glove makers, the forward orders will last them well into 2022,” he added.

From this perspective, he noted that glove stocks do seem defensive at this point of time, given that it is one of the few sectors that is seeing positive earnings momentum, offering very high dividend yield and trading at very low valuation relative to history.

As at noon break today, the big four rubber glove makers have wiped out RM13.65 billion worth of market capitalisation on Bursa Malaysia, due to the strong selling pressure that is possibly no thanks to the short selling ban that has been lifted as of today.

Stock

2021-01-04 20:36 | Report Abuse

Credit Suisse still POSITIVE on glove sector due to Attractive Valuation.
==================================================
TheEdge Mon, Jan 04, 2021 02:38pm - 5 hours ago


KUALA LUMPUR (Jan 4): Despite the availability of vaccines seen around the globe, Credit Suisse is still positive on the glove sector due to its inexpensive valuation and higher dividends.

Credit Suisse’s co-head of ASEAN securities research and head of research in Malaysia Danny Goh said the glove sector is trading at less than five times P/E multiple versus its historic average of 17%, and is at present offering a dividend of more than 10%.

“Thus, in terms of valuation and dividends point of view, gloves do provide very good value at this point of time,” said Goh, at Credit Suisse's 2021 ASEAN Conference media briefing today.

Based on feedback from the glove makers, Goh said the average selling price is still trending upwards on a quarter-on-quarter basis, noting that 2021 “earnings is pretty much already in the bag”.

“While the pandemic does pose some question marks on how long demand and selling prices could continue to stay firm, but if we were to rely on the feedback of some of the glove makers, the forward orders will last them well into 2022,” he added.

From this perspective, he noted that glove stocks do seem defensive at this point of time, given that it is one of the few sectors that is seeing positive earnings momentum, offering very high dividend yield and trading at very low valuation relative to history.

As at noon break today, the big four rubber glove makers have wiped out RM13.65 billion worth of market capitalisation on Bursa Malaysia, due to the strong selling pressure that is possibly no thanks to the short selling ban that has been lifted as of today.

Stock

2021-01-04 20:35 | Report Abuse

Credit Suisse still POSITIVE on glove sector due to Attractive Valuation.
==================================================
TheEdge Mon, Jan 04, 2021 02:38pm - 5 hours ago


KUALA LUMPUR (Jan 4): Despite the availability of vaccines seen around the globe, Credit Suisse is still positive on the glove sector due to its inexpensive valuation and higher dividends.

Credit Suisse’s co-head of ASEAN securities research and head of research in Malaysia Danny Goh said the glove sector is trading at less than five times P/E multiple versus its historic average of 17%, and is at present offering a dividend of more than 10%.

“Thus, in terms of valuation and dividends point of view, gloves do provide very good value at this point of time,” said Goh, at Credit Suisse's 2021 ASEAN Conference media briefing today.

Based on feedback from the glove makers, Goh said the average selling price is still trending upwards on a quarter-on-quarter basis, noting that 2021 “earnings is pretty much already in the bag”.

“While the pandemic does pose some question marks on how long demand and selling prices could continue to stay firm, but if we were to rely on the feedback of some of the glove makers, the forward orders will last them well into 2022,” he added.

From this perspective, he noted that glove stocks do seem defensive at this point of time, given that it is one of the few sectors that is seeing positive earnings momentum, offering very high dividend yield and trading at very low valuation relative to history.

As at noon break today, the big four rubber glove makers have wiped out RM13.65 billion worth of market capitalisation on Bursa Malaysia, due to the strong selling pressure that is possibly no thanks to the short selling ban that has been lifted as of today.

Stock

2021-01-04 20:33 | Report Abuse

Credit Suisse still POSITIVE on glove sector due to Attractive Valuation.
==================================================
TheEdge Mon, Jan 04, 2021 02:38pm - 5 hours ago


KUALA LUMPUR (Jan 4): Despite the availability of vaccines seen around the globe, Credit Suisse is still positive on the glove sector due to its inexpensive valuation and higher dividends.

Credit Suisse’s co-head of ASEAN securities research and head of research in Malaysia Danny Goh said the glove sector is trading at less than five times P/E multiple versus its historic average of 17%, and is at present offering a dividend of more than 10%.

“Thus, in terms of valuation and dividends point of view, gloves do provide very good value at this point of time,” said Goh, at Credit Suisse's 2021 ASEAN Conference media briefing today.

Based on feedback from the glove makers, Goh said the average selling price is still trending upwards on a quarter-on-quarter basis, noting that 2021 “earnings is pretty much already in the bag”.

“While the pandemic does pose some question marks on how long demand and selling prices could continue to stay firm, but if we were to rely on the feedback of some of the glove makers, the forward orders will last them well into 2022,” he added.

From this perspective, he noted that glove stocks do seem defensive at this point of time, given that it is one of the few sectors that is seeing positive earnings momentum, offering very high dividend yield and trading at very low valuation relative to history.

As at noon break today, the big four rubber glove makers have wiped out RM13.65 billion worth of market capitalisation on Bursa Malaysia, due to the strong selling pressure that is possibly no thanks to the short selling ban that has been lifted as of today.

Stock

2021-01-04 16:18 | Report Abuse

Look at Glovefinish/habisglove. they are all syndicates behind the scene to spread fear.
===============================================

Look at their comment history, only 1 counter they are attacking, it's an organized assault in which they open specific accounts to target specific counters. think about it, why glovefinish/habisglove never talked at TG/Harta/Kossan and any other gloves forum? they have their colleagues there taking care for them.

Retailers beware!

Stock

2021-01-04 14:12 | Report Abuse

@liewtx06- Good one!

Glovefinish/habisglove. they are all syndicates behind the scene to spread fear.
========================================================
Look at their comment history, only 1 counter they are attacking, it's an organized assault in which they open specific accounts to target specific counters. think about it, why glovefinish/habisglove never talked at TG/Harta/Kossan and any other gloves forum? they have their colleagues there taking care for them. so retailers beware!

Stock

2021-01-04 11:14 | Report Abuse

Wise words by Warrant Buffett
-------------------------------

No point talking about TA or FA when the price is crashing. If your conviction is strong, you either KEEP or BUY more. It's time for the transfer of wealth/money from the impatient/fearful to the patient/brave.

"Unless you can watch your stock holding decline by 50% without becoming panic-stricken, you should not be in the stock market." -Warren Buffett.

Stock

2021-01-03 15:19 | Report Abuse

Large Numbers Of Health Care And Frontline Workers Are Refusing Covid-19 Vaccine
---------------------------------------------------------------------------
Tommy Beers-Forbes

TOPLINE Despite the Covid-19 death count in the United States rapidly accelerating, a startlingly high percentage of health care professionals and frontline workers throughout the country—who have been prioritized as early receipts of the coronavirus vaccine—are reportedly hesitant or outright refusing to take it.

Dr. Nikhila Juvvadi, the chief clinical officer at Chicago's Loretto Hospital, said that a survey was administered in December, and 40% of the hospital staff said they would not get vaccinated.

A recent survey by the Kaiser Family Foundation found that 29% of healthcare workers were hesitant to receive the vaccine, citing concerns related to potential side effects and a lack of faith in the government to ensure the vaccines were safe.

Stock

2021-01-03 11:48 | Report Abuse

After talking down Glove stocks for the last Q of 2020, the IBs and fund managers will talk good about gloves for the 1st Q of 2021.

In 2020, Fund managers are aware that only wining stocks are Gloves. So after selling to lock in profits, they talk down Gloves in the 4th Quarter.

2021 is a different ball game. They will be quietly buying gloves because of the earnings.

Supermx is single digit only, could be 6 or 7, how cheap the stock it is.. if pe back to 10, price should be 9 to 10.

Only those who can think with wise brain only...

Stock

2021-01-03 11:19 | Report Abuse

Well said Persie!

Jason lim appears to be spooked by your comment lol

Posted by persie > Jan 3, 2021 10:44 AM | Report Abuse

Coming PE for supermx is single digit only, could be 6 or 7, how cheap the stock it is.. if pe back to 10, price should be 9 to 10.. Only those who can think with wise brain only...

Stock

2021-01-03 11:12 | Report Abuse

I stand by what I say, don't be fooled Jasoon lim.
Time will tell, be patient. Bro.
-------------------------------------
https://www.thestar.com.my/business/business-news/2021/01/02/glove-mak...

After talking down Glove stocks for the last Q of 2020, the IBs and fund managers will talk good about gloves for the 1st Q of 2021.

In 2020, Fund managers are aware that only wining stocks are Gloves. So after selling to lock in profits, they talk down Gloves in the 4th Quarter.

2021 is a different ball game. They will be quietly buying gloves because of the earnings.

Don't be fooled

Stock

2021-01-03 10:31 | Report Abuse

https://www.thestar.com.my/business/business-news/2021/01/02/glove-mak...

After talking down Glove stocks for the last Q of 2020, the IBs and fund managers will talk good about gloves for the 1st Q of 2021.

In 2020, Fund managers are aware that only wining stocks are Gloves. So after selling to lock in profits, they talk down Gloves in the 4th Quarter.

2021 is a different ball game. They will be quietly buying gloves because of the earnings.

Don't be fooled

Stock

2021-01-03 10:22 | Report Abuse

Yup, it reminds me of the song " who let the dogs out" lol.

Posted by vanness_lyh > Jan 2, 2021 11:39 PM | Report Abuse

Hmm dogs start barking here even it's holiday, are they panicking? Hehehe

Stock

2021-01-02 21:35 | Report Abuse

RMCO throughout Malaysia extended until March 31, says Ismail Sabri

https://www.theedgemarkets.com/article/rmco-throughout-malaysia-extend...

Don't sound good for recovery stock.

Some recovery stocks may have to rest in peace.

Stock

2021-01-02 20:48 | Report Abuse

@linheng- Spot on

Glove makers in for good run in 2021
===========================
https://www.thestar.com.my/business/business-news/2021/01/02/glove-mak...

After talking down Glove stocks for the last Q of 2020, the IBs and fund managers will talk good about gloves for the 1st Q of 2021. Lets watch if thats the case

In 2020, Fund managers are aware that only wining stocks are Gloves. So after selling to lock in profits, they talk down Gloves in the 4th Quarter.

2021 is a different ball game. They will be quietly buying gloves because of the earnings. Don't be fooled

Stock

2021-01-02 19:36 | Report Abuse

Well said bro !
-------------------------
Posted by 6996 > Jan 2, 2021 4:49 PM | Report Abuse

Supermax can earn you super profit in 2021, enormous cash flow. Take care if you do not know how to invest in a profitable company. Chart is not a crystal ball. Figures of profit dont lie

Stock

2021-01-02 15:57 | Report Abuse

Adequately vaccinating Americans will take 10 years at current pace.
--------------------------------------------------------------------
Dec. 30, 2020,
By Joe Murphy and Corky Siemaszko

The Trump administration's Covid-19 vaccine distribution program needs a major shot in the arm because at the current rate, it would take almost 10 years to inoculate enough Americans to get the pandemic under control, a jarring new NBC News analysis showed Tuesday.

The goal of Operation Warp Speed, a private-public partnership led by Vice President Mike Pence to produce and deliver safe and effective Covid-19 vaccines to the public, is to ensure that 80 percent of the country's 330.7 million people get the shots by late June.

To meet that goal, a little more than 3 million people would have to get the shots each day, the math shows.

Stock

2021-01-02 15:28 | Report Abuse

SUPERMAX complies with International Labour Standards & Ethics
------------------------------------------------------------------
Thats WHY No Labour /Covid 19 Issues- The MOST respected & profitable GLOVE manufacturer in Malaysia.

SEDEX is one of the world’s leading ethical trade service providers, working to improve working conditions in global supply chains. It provides practical tools, services and a community network to help companies improve their responsible and sustainable business practices, and source responsibly.

SMETA is an ethical audit format which reports on Sedex's four pillars of labour, health, safety and environment in reflecting good business ethics.

The Supermax Group is fully committed towards social compliance and strives to ensure that there are no forced labour practices at its factories and have implemented various initiatives towards this end.

Stock

2021-01-02 12:50 | Report Abuse

@ liewtz06- Well Said Bro.

Analysts only good at plucking data from imagination
Especially from The Star/Edge & IBs.
-----------------------------------------------------

Gloves bosses gave their best prediction based on their experiences and in-depth studies, maybe now market does not buy it. Perhaps, too much trust given to so called those half baked Analyst.

But if it's proven right, then the rally will start again. Depends on who you trust, the bosses who work on the ground or analysts plucking data from imagination.

Currently the market trust the news flow, but reversal cound come anytime when market found reality doesn't tally.

The vaccination speed may fall short of expectations like in the US. The duration of protection is unknown. % of Vaccines uptake by the public is unknown.

In fact there is an acute shortage of medical personnel to administer vaccines in US hospitals.

Potential of vaccine escape is unknown as infections remain high that could lead to higher opportunity of mutation and adaptability of virus towards current antibodies.


Too many uncertainties.

Stock

2021-01-01 21:04 | Report Abuse

Big Structural Shift in The Usage of Glove Globally to power the GLOVE sector
------------------------------------------------
With the heightened awareness toward hygiene , there is still ample room for growth of glove consumption in many countries post pandemic.

This Structural shift in the usage of gloves will triple the usage of gloves globally.

SUPERMAX being OBM and Own Distribution Centres & coupled with strong foothold in UK/EUROPE and USA- will be the biggest beneficiary.

Stock

2021-01-01 20:39 | Report Abuse

SUPERMAX complies with International Labour Standards & Ethics
------------------------------------------------------------------
Thats WHY No Labour /Covid 19 Issues- The MOST respected & profitable GLOVE manufacturer in Malaysia.

SEDEX is one of the world’s leading ethical trade service providers, working to improve working conditions in global supply chains. It provides practical tools, services and a community network to help companies improve their responsible and sustainable business practices, and source responsibly.

SMETA is an ethical audit format which reports on Sedex's four pillars of labour, health, safety and environment in reflecting good business ethics.

The Supermax Group is fully committed towards social compliance and strives to ensure that there are no forced labour practices at its factories and have implemented various initiatives towards this end.

SUPER TO THE MAX- The PRIDE of Malaysians.

Stock

2021-01-01 16:47 | Report Abuse

Foreign Funds accumulated SUPERMAX heavily in December.
--------------------------------------------------
63.5 mil shares in Dec,
11.8 mil shares in Nov,
18.5 mil shares in Oct,
69600 shares in Sept,
1.25 mil shares in Aug and
248k shares in July.

Total 95.4 mil shares over the past 6 months

FF bought 63.5 million SUCB shares during the December 2020 cheap sale.


https://fintel.io/so/us/spmxf

Stock

2021-01-01 16:20 | Report Abuse

A price to earnings ratio is the best valuation method for the BIG 4.

A comparison solely based on current market value is MISLEADING.
-----------------------------------------------------------

Posted by williamtkb > Jan 1, 2021 3:23 PM | Report Abuse

TG 6.12×3=18.36
Harta 12.14
Supermax 6.01 ×2 =12.02
kossan 4.50×2=9
As of 2020 closing price compare 2020 opening price, are you dare to sailang in 2021?

Timeout

2021-01-01 14:58 | Report Abuse

Hello Bro, why so angry- Government boh lui, how to proceed with the project.

Stock

2021-01-01 13:03 | Report Abuse

Thats the problem with the so called experts- especially the ones from IBs.-
They tend to have biased views especially on Gloves and Supermx in particular. - as if the Vaccines will make Covid 19 disappear in the next 3 months, so delusional and refuse to face facts.

WHO officials recently warned that the development of COVID-19 vaccines is no guarantee that the virus will be eradicated.

WHO officials are predicting that the “destiny” of the COVID-19 virus is to become ENDEMIC, suggesting it could continue to spread through the population at a steady rate despite a global vaccination effort.

We have to learn to live with the virus for a considerable time from the looks of it.

Hence ,stay safe and adhere to the SOPs.
-------------------------------------------------------
@ Liewtz06

Experts normally look at the back mirror not the future.
Supermax has secured all NBR needs for it's expansion, according to UOB KayHian's analysis. So there is no difference. So, they have confirm there'll be no oversupply of NBR gloves, means TG and SPMX all will benefit from this.

Stock

2021-01-01 12:04 | Report Abuse

Latest News.

A Sobering reminder by WHO - Vaccines is no guarantee that the virus will be eradicated.
------------------------------------------------------------------------------------------

WHO officials are predicting that the “destiny” of the COVID-19 virus is to become endemic, suggesting it could continue to spread through the population at a steady rate despite a global vaccination effort.

At a news conference Tuesday, several senior WHO officials warned that the development of COVID-19 vaccines is no guarantee that the virus will be eradicated

“It appears at present that the destiny of SARS-CoV-2 (the virus that causes COVID-19) is to become endemic,” said David Heymann, the London-based chair of the WHO's strategic and technical advisory group for infectious hazards.


Stay Safe Folks- Adhere to the SOPs.

Stock

2020-12-31 16:57 | Report Abuse

Naysayers out to create PANIC & BUY CHEAP TACTIC BACKFIRED TODAY
-----------------------------------------------------------------------
These naysayers are not here to help you.

Once it's green, you won't even see a glimpse of them, but they will hound you with fear mongering once its red. "

Those who posted SELL,SELL,SELL/ RUNN RUNN got nothing to sell and are here to create panic so that they can buy cheaper

SUPER TO THE MAX CLOSED GREEN

NAYSAYERS RUNN RUNN RUNN TO THE CAVE & HIBERNATE - YOU CLOWNS !

Stock

2020-12-31 11:23 | Report Abuse

Yup, Naysayers out to create PANIC & BUY CHEAP.
-----------------------------------------------------------------------
These naysayers are not here to help you.

Once it's green, you won't even see a glimpse of them, but they will hound you with fear mongering once its red. "

Those who posted SELL,SELL,SELL got nothing to sell and are here to create panic so that they can buy cheaper

Stock

2020-12-31 10:23 | Report Abuse

Yup, Naysayers out to create PANIC & BUY CHEAP.
-----------------------------------------------------------------------
These naysayers are not here to help you.

Once it's green, you won't even see a glimpse of them, but they will hound you with fear mongering once its red. "

Those who posted SELL,SELL,SELL got nothing to sell and are here to create panic so that they can buy cheaper

Stock

2020-12-31 09:22 | Report Abuse

Yup, Naysayers out to create PANIC & BUY CHEAP.
-----------------------------------------------------------------------
These naysayers are not here to help you.

Once it's green, you won't even see a glimpse of them, but they will hound you with fear mongering once its red. "

Those who posted SELL,SELL,SELL got nothing to sell and are here to create panic so that they can buy cheaper

Stock

2020-12-31 08:55 | Report Abuse

Yup, Naysayers out to create PANIC & BUY CHEAP.
-----------------------------------------------------------------------
These naysayers are not here to help you.

Once it's green, you won't even see a glimpse of them, but they will hound you with fear mongering once its red. "

Those who posted SELL,SELL,SELL got nothing to sell and are here to create panic so that they can buy cheaper

Stock

2020-12-30 21:00 | Report Abuse

SUPER SET TO SURGE TOMORROW IN THE ABSENCE OF CIMB MANIPULATING SUPERMAX SHARE PRICE

SUPER TO THE MAX IS STILL TH BEST STOCK IN BURSA- TIME WILL TELL- B PATIENT YA.

HARD LUCK TO ALL THE BARKING DOGGIES & NAYSAYERS WHO STLL WANT TO COLLECT CHEAP CHEAP.

Stock

2020-12-30 20:49 | Report Abuse

CIMB MANIPULATED SUPEMAX AT LAST FEW MINUTES BEFORE CLOSE.
==========================================
CIMB SOLD OFF SUPERMAX HEAVILY AT LAST MINUTE TO COVER MASSIVE LOSSES DUE TO MATURING CALL WARRANTS.

SUPER SET TO SURGE TOMORROW IN THE ABSENCE OF CIMB MANIPULATING SUPERMAX SHARE PRICE

SUPER TO THE MAX IS STILL TH BEST STOCK IN BURSA- TIME WILL TELL- B PATIENT YA.

HARD LUCK TO ALL THE BARKING DOGGIES & NAYSAYERS WHO STLL WANT TO COLLECT CHEAP CHEAP.

THEY KNOW THE VALUE OF SUPERMAX.


SUPER TO THE MAX WILL RETURN WITH A BANG!!!!


WORLD WILL FACE SHORTAGE OF GLOVES FOR ANOTHER 2 YEARS. - AT LEAST.

Stock

2020-12-30 13:21 | Report Abuse

MERCATOR MEDICAL up 10.24 % Yesterday.
-----------------------------------------
Mercator Medical SA
WSE: MRC

420.00 PLN +39.00 (10.24%)

29 Dec, 5:04 pm GMT+1 ·

News & Blogs

2020-12-30 13:07 | Report Abuse

Silly comment- this GLOVES not Oil & Gas. Grow up will you.
------------------------------------
Sslee Another Dayang in the making
30/12/2020 7:42 AM